Coloplast | COLOB - Selling And Administration Expenses


Coloplast reported 2.64B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Ambu A/S DKK 684M 5M Mar/2026
Avanos Medical USD 77.7M 1.1M Mar/2026
Brookdale Senior Living USD 4.22B 4.19B Mar/2026
Cencora USD 1.8B 46.42M Dec/2025
Coloplast 2.64B 52M Dec/2025
Computer Programs Systems USD 51.62M 109.74M Dec/2025
Encompass Health USD 58.2M 10.2M Mar/2026
Enovis USD 282.81M 12.37M Mar/2026
GE HealthCare Technologies USD 1.11B 145M Dec/2025
OPKO Health USD 50.52M 3.28M Dec/2025
Pediatrix Medical Group USD 65.68M 4.89M Dec/2025
Veradigm USD 27.28M 5.24M Dec/2022
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026